Log In
Print
BCIQ
Print
Print this Print this
 

Travoprost-loaded punctum plug (OTX-TP2)

  Manage Alerts
Collapse Summary General Information
Company Ocular Therapeutix Inc.
DescriptionHydrogel-based punctum plug that delivers sustained-release travoprost over 2 months
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today